Figure 3 | Journal of Human Hypertension

Figure 3

From: Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Figure 3

Open circles are seated, clinic SBP treatment differences between the group that received AZL-M 40 mg and the RAM group. Closed circles are the treatment differences between the AZL-M 80 mg group and the RAM group. The median clinic SBP at baseline was 160.3 mm Hg. Baseline estimated glomerular filtration rate (eGFR) categories expressed as ml min−1 per 1.73 m2. *P<0.05 vs RAM. BMI, body mass index.

Back to article page